Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Lifeward Ltd.RWLK · Entity 7620 | Snr VP, R&D and Regulatory | July 02, 2020 | July 07, 2020 |
| Nano-X Imaging Ltd.NNOX · Entity 7098 | General Manager, ARC Division | October 10, 2026 | October 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Lifeward Ltd.
Report date July 02, 2020 · Filed July 07, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, par value NIS 0.25 per shareSEC Table I · non-derivative | IndirectESOP | 64,995 |
Reported balance
After 2020-07-02 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2020-07-02 · Grant · Acquired 60,000 · Balance 64,995 F1: Represents 60,000 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on July 2, 2020 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal yearly instalments starting on the first anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents 60,000 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on July 2, 2020 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal yearly instalments starting on the first anniversary of the date of grant.
Nano-X Imaging Ltd.
Report date October 10, 2026 · Filed October 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 28,283 |
Reported balance
After 2026-10-10 transaction · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · 2026-10-10 · Grant · Acquired 28,283 · Balance 28,283 F1: The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 28,283 ordinary shares represented by 28,283 restricted share units ("RSUs"), pursuant to the Issuer's 2019 Equity Incentive Plan. F2: The 28,283 RSUs reported in this row vest and settle for underlying ordinary shares in four equal semi-annual installments of 25% each following the vesting commencement date of August 13, 2026-- on February 13, 2027, August 13, 2027, February 13, 2028 and August 13, 2028, subject, in each case, to the Reporting Person's continuous employment by the Issuer as of the applicable vesting date, such that by the two-year anniversary of the vesting commencement date (August 13, 2028) all underlying shares will be issued to the Reporting Person. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2026-10-10 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 10,000 F3: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2026-10-10 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 10,000 F3: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. F4: The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer on April 16, 2024 and that vest and settle for underlying ordinary shares in 16 equal quarterly installments (each for 6.25% of the RSUs granted) such that by the four-year anniversary of the grant date (April 16, 2028) all underlying shares will be issued to the Reporting Person. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 39,474 |
Reported balance
Holding disclosure · report date 2026-10-10 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 39,474 F3: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. F5: The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer on February 5, 2026, of which 50% vest and settle for underlying ordinary shares on the 12-month anniversary of the grant date (February 5, 2027) and the remaining 50% on the 24-month anniversary of the grant date (February 5, 2028). |
| Stock Option (right to buy ordinary shares)SEC Table II · derivative / convertible security · Conversion / exercise price $49.68 · Expires 2031-01-18 | Direct | 100,000 |
Reported balance
Holding disclosure · report date 2026-10-10 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 100,000 F3: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. F6: The options reported in this row were granted to the Reporting Person by the Issuer on January 18, 2021 and are fully vested and exercisable as of the date of this report. |
| Stock Option (right to buy ordinary shares)SEC Table II · derivative / convertible security · Conversion / exercise price $17.63 · Expires 2032-03-28 | Direct | 25,000 |
Reported balance
Holding disclosure · report date 2026-10-10 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 25,000 F3: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. F7: The options reported in this row were granted to the Reporting Person by the Issuer on March 28, 2022 and are fully vested and exercisable as of the date of this report. |
| Stock Option (right to buy ordinary shares)SEC Table II · derivative / convertible security · Conversion / exercise price $11.52 · Expires 2033-05-23 | Direct | 33,500 |
Reported balance
Holding disclosure · report date 2026-10-10 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 33,500 F3: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. F8: The options reported in this row were granted to the Reporting Person by the Issuer on May 23, 2023 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable by the four-year anniversary of the grant date (May 23, 2027). |
Filing footnotes · ownership attribution and instrument terms
F1: The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 28,283 ordinary shares represented by 28,283 restricted share units ("RSUs"), pursuant to the Issuer's 2019 Equity Incentive Plan.
F2: The 28,283 RSUs reported in this row vest and settle for underlying ordinary shares in four equal semi-annual installments of 25% each following the vesting commencement date of August 13, 2026-- on February 13, 2027, August 13, 2027, February 13, 2028 and August 13, 2028, subject, in each case, to the Reporting Person's continuous employment by the Issuer as of the applicable vesting date, such that by the two-year anniversary of the vesting commencement date (August 13, 2028) all underlying shares will be issued to the Reporting Person.
F3: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
F4: The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer on April 16, 2024 and that vest and settle for underlying ordinary shares in 16 equal quarterly installments (each for 6.25% of the RSUs granted) such that by the four-year anniversary of the grant date (April 16, 2028) all underlying shares will be issued to the Reporting Person.
F5: The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer on February 5, 2026, of which 50% vest and settle for underlying ordinary shares on the 12-month anniversary of the grant date (February 5, 2027) and the remaining 50% on the 24-month anniversary of the grant date (February 5, 2028).
F6: The options reported in this row were granted to the Reporting Person by the Issuer on January 18, 2021 and are fully vested and exercisable as of the date of this report.
F7: The options reported in this row were granted to the Reporting Person by the Issuer on March 28, 2022 and are fully vested and exercisable as of the date of this report.
F8: The options reported in this row were granted to the Reporting Person by the Issuer on May 23, 2023 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable by the four-year anniversary of the grant date (May 23, 2027).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 10, 2026 Filed Oct 13, 2026 11:46 UTC | Nano-X Imaging Ltd. NNOX · Entity 7098 | GrantOrdinary Shares | 28,283 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-108728 · ownership.xml · nonDerivative · entry 1 Koren Ofir · CIK 0001661277 · General Manager, ARC Division 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,283 F1 · kind: The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 28,283 ordinary shares represented by 28,283 restricted share units ("RSUs"), pursuant to the Issuer's 2019 Equity Incentive Plan. F2 · balance_after: The 28,283 RSUs reported in this row vest and settle for underlying ordinary shares in four equal semi-annual installments of 25% each following the vesting commencement date of August 13, 2026-- on February 13, 2027, August 13, 2027, February 13, 2028 and August 13, 2028, subject, in each case, to the Reporting Person's continuous employment by the Issuer as of the applicable vesting date, such that by the two-year anniversary of the vesting commencement date (August 13, 2028) all underlying shares will be issued to the Reporting Person. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 20:56 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.25 per share | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-20-001983 · zk2024650.xml · nonDerivative · entry 1 Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 64,995 F1 · shares: Represents 60,000 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on July 2, 2020 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal yearly instalments starting on the first anniversary of the date of grant. Read SEC document |
| June 07, 2019 Filed Jun 10, 2019 20:09 UTC | Lifeward Ltd. RWLK · Entity 7620 | SaleOrdinary Shares, par value NIS 0.25 per share | 150 | $6.51 | $976.50 |
DisclosureSEC source: 0001213900-19-010421 · doc4.xml · nonDerivative · entry 3 Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,995 Read SEC document |
| June 07, 2019 Filed Jun 10, 2019 20:09 UTC | Lifeward Ltd. RWLK · Entity 7620 | SaleOrdinary Shares, par value NIS 0.25 per share | 108 | $6.52 | $704.16 |
DisclosureSEC source: 0001213900-19-010421 · doc4.xml · nonDerivative · entry 2 Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,145 Read SEC document |
| June 07, 2019 Filed Jun 10, 2019 20:09 UTC | Lifeward Ltd. RWLK · Entity 7620 | SaleOrdinary Shares, par value NIS 0.25 per share | 100 | $6.50 | $650.00 |
DisclosureSEC source: 0001213900-19-010421 · doc4.xml · nonDerivative · entry 1 Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,253 Read SEC document |
| June 01, 2019 Filed Jun 6, 2019 20:01 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.01 per share | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-19-010194 · doc4.xml · nonDerivative · entry 1 Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 5,353 F1 · shares: (1) Represents 3,750 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on June 1, 2019 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in three equal yearly installments starting on the first anniversary of the date of grant. Read SEC document |
| May 03, 2018 Filed May 7, 2018 12:55 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOption (Right to buy) · Derivative | 65,625 | $0.00 Strike: $1.08 | $0.00 |
DisclosureSEC source: 0001607962-18-000026 · wf-form4_152569771099390.xml · derivative · entry 2 Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,625 Underlying: Ordinary Shares, par value NIS 0.01 per share · 65,625 shares Expires 2028-05-03 F2 · derivative.exercise_date: Represents stock options granted under the 2014 Plan on May 3, 2018. One-fourth of the options become vested and exercisable on the first anniversary of the date of the grant, with the remaining options vesting in twelve equal quarterly installments thereafter. Read SEC document |
| May 03, 2018 Filed May 7, 2018 12:55 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.01 per share | 13,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001607962-18-000026 · wf-form4_152569771099390.xml · nonDerivative · entry 1 Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 40,091 F1 · shares: Represents 13,125 Ordinary Shares issuable upon the vesting of restricted stock units ("RSUs") granted under the ReWalk Equity Incentive Plan (the "2014 Plan") on May 3, 2018. The RSUs vest in four equal yearly installments starting on the first anniversary of the date of grant. Read SEC document |
| October 05, 2017 Filed Oct 6, 2017 21:27 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.01 per share | 13,401 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-17-009767 · wf-form4_150732524690167.xml · nonDerivative · entry 1 Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 26,966 F1 · shares: Represents 13,401 Ordinary Shares issuable upon the vesting of restricted stock units ("RSUs") granted under the ReWalk Robotics Ltd. Incentive Compensation Plan (the "2014 Plan") on October 5, 2017 as part of the equity exchange program, which commenced on September 6, 2017 and expired on October 4, 2017. The RSUs vest in three equal annual installments starting on the first anniversary of the date of grant, and may only be settled in Ordinary Shares. Read SEC document |
| October 04, 2017 Filed Oct 6, 2017 21:27 UTC | Lifeward Ltd. RWLK · Entity 7620 | Disposition to issuerOption (Right to buy) · Derivative | 17,950 | Not disclosed Strike: $9.44 | Not disclosed |
DisclosureSEC source: 0001628280-17-009767 · wf-form4_150732524690167.xml · derivative · entry 4 Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares, par value NIS 0.01 per share · 17,950 shares Expires 2026-05-18 F4 · price: Represents stock options granted under the 2014 Plan on May 18, 2016. The options were cancelled on October 4, 2017 as part of the equity exchange program and were replaced with RSUs. One fourth of the cancelled options become vested and exercisable on the first anniversary of the date of the grant, with the remaining options vesting in twelve equal quarterly installments thereafter. F4 · derivative.exercise_date: Represents stock options granted under the 2014 Plan on May 18, 2016. The options were cancelled on October 4, 2017 as part of the equity exchange program and were replaced with RSUs. One fourth of the cancelled options become vested and exercisable on the first anniversary of the date of the grant, with the remaining options vesting in twelve equal quarterly installments thereafter. Read SEC document |
| October 04, 2017 Filed Oct 6, 2017 21:27 UTC | Lifeward Ltd. RWLK · Entity 7620 | Disposition to issuerOption (Right to buy) · Derivative | 25,000 | Not disclosed Strike: $8.00 | Not disclosed |
DisclosureSEC source: 0001628280-17-009767 · wf-form4_150732524690167.xml · derivative · entry 3 Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 25,000 shares Expires 2025-09-25 F3 · price: Represents stock options granted under the 2014 Plan on September 25, 2015. The options were cancelled on October 4, 2017 as part of the equity exchange program and were replaced with RSUs. The cancelled options become vested and exercisable in 12 equal quarterly installments starting on the first anniversary of the date of grant. F3 · derivative.exercise_date: Represents stock options granted under the 2014 Plan on September 25, 2015. The options were cancelled on October 4, 2017 as part of the equity exchange program and were replaced with RSUs. The cancelled options become vested and exercisable in 12 equal quarterly installments starting on the first anniversary of the date of grant. Read SEC document |
| October 04, 2017 Filed Oct 6, 2017 21:27 UTC | Lifeward Ltd. RWLK · Entity 7620 | Disposition to issuerOption (Right to buy) · Derivative | 5,657 | Not disclosed Strike: $20.77 | Not disclosed |
DisclosureSEC source: 0001628280-17-009767 · wf-form4_150732524690167.xml · derivative · entry 2 Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,657 shares Expires 2024-12-15 F2 · price: Represents stock options granted under the 2014 Plan on December 15, 2014. The options were cancelled on October 4, 2017 as part of the equity exchange program and were replaced with RSUs. The cancelled options become vested and exercisable in 12 equal quarterly installments starting on the first anniversary of the date of grant. F2 · derivative.exercise_date: Represents stock options granted under the 2014 Plan on December 15, 2014. The options were cancelled on October 4, 2017 as part of the equity exchange program and were replaced with RSUs. The cancelled options become vested and exercisable in 12 equal quarterly installments starting on the first anniversary of the date of grant. Read SEC document |
| April 18, 2017 Filed Apr 20, 2017 16:19 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOption (Right to buy) · Derivative | 37,500 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001628280-17-003970 · wf-form4_149270517795322.xml · derivative · entry 2 Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Ordinary Shares, par value NIS 0.01 per share · 37,500 shares Expires 2027-04-18 F2 · derivative.exercise_date: Represents stock options granted under the 2014 Plan on April 18, 2017. One-fourth of the options become vested and exercisable on the first anniversary of the date of the grant, with the remaining options vesting in twelve equal quarterly installments thereafter. Read SEC document |
| April 18, 2017 Filed Apr 20, 2017 16:19 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.01 per share | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-17-003970 · wf-form4_149270517795322.xml · nonDerivative · entry 1 Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 13,565 F1 · shares: Represents 7,500 Ordinary Shares issuable upon the vesting of restricted stock units ("RSUs") granted under the ReWalk Equity Incentive Plan (the "2014 Plan") on April 18, 2017. The RSUs vest in four equal annual installments starting on the first anniversary of the date of grant, and may only be settled in Ordinary Shares. Read SEC document |
| January 06, 2017 Filed Mar 30, 2017 14:26 UTC | Lifeward Ltd. RWLK · Entity 7620 | Exercise / conversionOption (Right to buy) · Derivative | 4,720 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001628280-17-003090 · wf-form4_149088399318915.xml · derivative · entry 6 Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,310 Underlying: Ordinary Shares, par value NIS 0.01 per share · 4,720 shares Expires 2023-07-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Represents the exercise of stock options granted to the reporting person pursuant to the ReWalk 2012 Equity Incentive Plan. The stock options vested and became exercisable in 12 equal quarterly installments starting on August 1, 2014. Read SEC document |
| January 06, 2017 Filed Mar 30, 2017 14:26 UTC | Lifeward Ltd. RWLK · Entity 7620 | SaleOrdinary Shares, par value NIS 0.01 per share | 4,720 | $3.50 | $16,520.00 |
DisclosureSEC source: 0001628280-17-003090 · wf-form4_149088399318915.xml · nonDerivative · entry 4 Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 6,065 F2 · kind: Represents an open market sell effected pusuant to a 10B5-1 plan Read SEC document |
| January 06, 2017 Filed Mar 30, 2017 14:26 UTC | Lifeward Ltd. RWLK · Entity 7620 | Exercise / conversionOrdinary Shares, par value NIS 0.01 per share | 4,720 | $1.32 | $6,230.40 |
DisclosureSEC source: 0001628280-17-003090 · wf-form4_149088399318915.xml · nonDerivative · entry 3 Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 10,785 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the exercise of stock options granted to the reporting person pursuant to the ReWalk 2012 Equity Incentive Plan. The stock options vested and became exercisable in 12 equal quarterly installments starting on August 1, 2014. Read SEC document |
| January 03, 2017 Filed Mar 30, 2017 14:26 UTC | Lifeward Ltd. RWLK · Entity 7620 | Exercise / conversionOption (Right to buy) · Derivative | 500 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001628280-17-003090 · wf-form4_149088399318915.xml · derivative · entry 5 Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,030 Underlying: Ordinary Shares, par value NIS 0.01 per share · 500 shares Expires 2023-07-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Represents the exercise of stock options granted to the reporting person pursuant to the ReWalk 2012 Equity Incentive Plan. The stock options vested and became exercisable in 12 equal quarterly installments starting on August 1, 2014. Read SEC document |
| January 03, 2017 Filed Mar 30, 2017 14:26 UTC | Lifeward Ltd. RWLK · Entity 7620 | SaleOrdinary Shares, par value NIS 0.01 per share | 500 | $3.00 | $1,500.00 |
DisclosureSEC source: 0001628280-17-003090 · wf-form4_149088399318915.xml · nonDerivative · entry 2 Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 6,065 F2 · kind: Represents an open market sell effected pusuant to a 10B5-1 plan Read SEC document |
| January 03, 2017 Filed Mar 30, 2017 14:26 UTC | Lifeward Ltd. RWLK · Entity 7620 | Exercise / conversionOrdinary Shares, par value NIS 0.01 per share | 500 | $1.32 | $660.00 |
DisclosureSEC source: 0001628280-17-003090 · wf-form4_149088399318915.xml · nonDerivative · entry 1 Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 6,565 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the exercise of stock options granted to the reporting person pursuant to the ReWalk 2012 Equity Incentive Plan. The stock options vested and became exercisable in 12 equal quarterly installments starting on August 1, 2014. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.